Wegovy online: the pill, the pen, cost, coupon and side effects
A licensed Zealthy provider reviews your health history online and prescribes Wegovy when it is appropriate. Our insurance team then files the prior authorization.
- 14.9% average weight loss at 68 weeks on Wegovy 2.4 mg in the STEP 1 trial (placebo: 2.4%)1
- Brand Wegovy copay as low as $25/mo when your plan covers it*
- No live appointment needed to start
- For eligible adults in all 50 states
Wegovy carries a boxed warning. Read the important safety information.
What is Wegovy used for?
Weight management, together with diet and exercise. Novo Nordisk makes Wegovy, and its active ingredient is semaglutide, a GLP-1 medicine. You can take it as a weekly injection pen or, since its December 2025 approval, a daily tablet.2,3
Is there a pill version of Wegovy?
Yes. The FDA approved Wegovy tablets for adults on December 22, 2025.3 There are four strengths, from 1.5 mg to 25 mg, and you swallow one each morning on an empty stomach. See Wegovy pill vs. pen.
What if my plan will not pay for Wegovy?
You can pay Novo Nordisk’s self-pay price for the brand, or ask a Zealthy provider about compounded semaglutide, which starts at $106 a month with a 3-month supply. It is not FDA-approved, and the FDA does not review compounded drugs for safety, effectiveness or quality.4
*Your plan sets your copay. It can be as low as $25 a month when a commercial plan covers Wegovy. Coverage is never guaranteed, and an active Zealthy membership is required. See Wegovy cost. †$199 billed monthly, or from $106 a month with a 3-month supply, shipping included. Not FDA-approved. Membership is billed separately: $39 for month one, then $135 monthly.
Safety summary: Wegovy’s boxed warning concerns a possible risk of thyroid C-cell tumors. Do not take it if you, or a close relative, has had medullary thyroid carcinoma, or if you have MEN 2. Read the full safety information.
STEP 1 trial: 14.9% average weight loss on Wegovy 2.4 mg
STEP 1 followed 1,961 adults with obesity, or overweight plus a weight-related condition, and no diabetes. After 68 weeks of weekly Wegovy 2.4 mg and a lifestyle program, average weight loss was 14.9%. On placebo it was 2.4%.1
Arithmetic on one trial average (STEP 1, Wegovy 2.4 mg weekly, 68 weeks), not a prediction. Individual results vary with dose, time on treatment and health.
What is Wegovy, and how does it work?
Wegovy is brand-name semaglutide for weight management. When it is appropriate, a Zealthy provider can prescribe the brand, or compounded semaglutide if the brand is out of reach.
| Feature | Brand WegovyWhen your plan covers it | Compounded semaglutideThe lower-cost route |
|---|---|---|
| FDA status | FDA-approved2 | Not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality4 |
| Forms | Weekly pen or daily tablet | Weekly injection from a vial |
| Trial evidence | The STEP, SELECT and OASIS trials | None of its own. Wegovy’s results do not carry over |
| Medication cost | Copay can be as low as $25/mo when your plan covers it | $199/mo, or from $106/mo with a 3-month supply |
| Where it comes from | Your own pharmacy | Shipped by a partner pharmacy |
| Zealthy membership | $39 in month one, $135 a month from then on. Medication is not included. | |
How Wegovy works
Semaglutide mimics GLP-1, a gut hormone, and shares 94% of its structure. It acts on GLP-1 receptors in brain areas that regulate appetite, which is thought to be why people take in fewer calories. It also slows stomach emptying. Its half-life is about one week, which suits a weekly pen.2 New to the class? Read what GLP-1 means.
Wegovy 7.2 mg (Wegovy HD)
Wegovy HD is a 7.2 mg weekly pen that the FDA approved on March 19, 2026.5 It is for adults who have tolerated 2.4 mg for at least four weeks and need more weight reduction.2 In the 72-week STEP UP trial, average weight loss was 18.7% on 7.2 mg, 15.6% on 2.4 mg and 3.9% on placebo.6
Who Wegovy is approved for
- Adults with obesity (generally a BMI of 30 or higher), or overweight (generally 27 or higher) with a weight-related condition, to lose weight and keep it off.
- Ages 12 and up with obesity (injection only).
- Adults who have heart disease together with obesity or overweight, to reduce the chance of cardiovascular death, heart attack and stroke.
- Adults with the liver disease MASH and moderate to advanced scarring (injection only).
Always alongside a lower-calorie diet and added physical activity. Not for use with other GLP-1 medicines.2
Wegovy pill vs. Wegovy pen
Wegovy tablets contain semaglutide, taken once a day and built up to 25 mg. They are approved for adults only. The drug matches the pen. The routine, storage and price differ.2
| Feature | Wegovy pillTablet, every day | Wegovy penInjection, every week |
|---|---|---|
| How you take it | First thing each morning, stomach empty, with at most 4 oz of plain water | Under the skin of the abdomen, thigh or upper arm, any time of day |
| Step-up schedule | 1.5, 4 and 9 mg for 30 days apiece, then 25 mg | 0.25, 0.5, 1 and 1.7 mg for 4 weeks apiece, then 2.4 mg |
| Long-term dose | 25 mg daily | 1.7 mg or 2.4 mg weekly, up to 7.2 mg |
| Main weight trial | OASIS 4: 13.6% at 64 weeks, placebo 2.2%7 | STEP 1: 14.9% at 68 weeks, placebo 2.4%1 |
| Storage | Room temperature, 68°F to 77°F, in its bottle | Refrigerator, 36°F to 46°F |
| Missed dose | Skip it and take tomorrow’s as normal | Take it only when the next dose is over 48 hours away |
| Self-pay price | $149 (1.5 mg), $199 (4 mg) or $299 (9 mg, 25 mg) a month | $349 a month. $399 for 7.2 mg |
| If your plan covers Wegovy | Either form can drop to $25 a month with the savings offer | |
Rules from the Wegovy label.2 Prices as of November 2026.8 The two trials were separate, so this is not a head-to-head result.
How to take Wegovy tablets
- On waking, take one tablet before you eat or drink anything.
- Use plain water, 4 ounces at most, and swallow the tablet whole.
- Leave 30 minutes or more before you eat, drink anything else or take other oral medicines.
- Never split, crush or chew it, and keep to one a day.2
Wegovy pill dosing schedule
- Days 1 to 30: 1.5 mg
- Days 31 to 60: 4 mg
- Days 61 to 90: 9 mg
- Day 91 onward: 25 mg, the maintenance dose2
Is the pill as effective as the pen?
No trial has compared them. The label reports similar semaglutide blood levels from the 25 mg tablet and the 2.4 mg injection in people without type 2 diabetes. The tablet has not been studied for weight loss in people with type 2 diabetes.2
Switching between pill and pen
Your provider decides. Coming off the 2.4 mg pen, you take your first 25 mg tablet one week after the final injection. Coming off the tablet, the first injection is the next day.2
Wegovy clinical trial results
In its main trials, Wegovy produced average weight loss of about 14% to 19%, depending on the dose and form. These are averages, and individual results vary.
| Trial | Who was studied | Dose and length | On Wegovy | Comparison |
|---|---|---|---|---|
| STEP 11 | 1,961 adults, no diabetes | 2.4 mg weekly, 68 weeks | 14.9% | Placebo 2.4% |
| STEP 59 | 304 adults | 2.4 mg weekly, 104 weeks | 15.2% | Placebo 2.6% |
| STEP UP6 | 1,407 adults with obesity | 7.2 mg weekly, 72 weeks | 18.7% | 2.4 mg 15.6%. Placebo 3.9% |
| OASIS 47 | 307 adults, no diabetes | 25 mg tablet daily, 64 weeks | 13.6% | Placebo 2.2% |
| SELECT10 | 17,604 adults with heart disease, no diabetes | Weekly injection, about 40 months | Heart attack, stroke or cardiovascular death: 6.5% | Placebo 8.0% |
| SURMOUNT-511 | 751 adults with obesity | 1.7 mg or 2.4 mg weekly, 72 weeks | 13.7% | Tirzepatide 20.2% |
Percentages are average loss of starting weight unless stated. STEP 1 was funded by Novo Nordisk and SURMOUNT-5 by Eli Lilly, the maker of tirzepatide (Zepbound®).
Results in type 2 diabetes, and after stopping
People with type 2 diabetes lost less: 9.6% in the STEP 2 trial.2 Stopping matters too. In STEP 4, adults who switched to placebo after 20 weeks regained 6.9% over the next 48 weeks, while those who continued lost another 7.9%.12
How to get Wegovy online with Zealthy
It all happens in the Zealthy app or portal. There is no clinic to visit.
1. Answer the health questions
Complete the online intake: weight, medical history, current medicines. Membership is $39 to start and $135 a month from month two. Medication is separate.

2. A licensed provider reviews it
A U.S.-licensed physician or nurse practitioner decides whether Wegovy is appropriate for you. No live appointment is required, and questions come by message.

3. Our insurance team contacts your plan
For brand Wegovy we submit the prior authorization. When your plan covers it, the copay can be as low as $25 a month. Approval is the plan’s decision.

4. Your prescription is filled
Brand Wegovy goes to your own pharmacy. Compounded semaglutide, if prescribed, ships from a partner pharmacy and usually arrives within 2 to 9 business days. It is not FDA-approved.

5. Step up with your care team
The pen moves through four starter doses in 16 weeks. Message your care team any time, add a monthly video or phone visit if you like, and lean on your weight loss coach.

What a Zealthy membership covers
- Review by a licensed provider
- An insurance coordination team for prior authorizations
- Unlimited secure messaging with your care team
- Optional monthly video or phone visits
- A weight loss coach
- The Zealthy app (iOS and Android) and online portal
$39 for your first month, then $135 monthly. Medication is billed on its own.

Wegovy side effects: how common each one is
Nausea is the most common Wegovy side effect: 44% of adults taking the 2.4 mg pen reported it, against 16% on placebo. Stomach and bowel effects were most frequent while the dose was rising.2
| Side effect | Placebo | Wegovy 2.4 mg |
|---|---|---|
| Nausea | 16% | 44% |
| Diarrhea | 16% | 30% |
| Vomiting | 6% | 24% |
| Constipation | 11% | 24% |
| Stomach pain | 10% | 20% |
| Headache | 10% | 14% |
| Tiredness | 5% | 11% |
| Indigestion | 3% | 9% |
| Dizziness | 4% | 8% |
| Bloating | 5% | 7% |
| Belching | Under 1% | 7% |
| Heartburn | 3% | 5% |
| Hair loss | 1% | 3% |
Adults in the weight management trials, from the Wegovy label.2
Ways to ease nausea
Novo Nordisk lists these tips:13
- Eat slowly.
- Choose bland, low-fat foods like crackers, toast and rice.
- Try watery foods such as soup.
- Avoid greasy food and lying down after meals.
- Drink fluids so you do not get dehydrated.
Get medical help right away for
- Severe stomach pain that will not go away, with or without vomiting.
- Upper stomach pain with fever, yellow skin or eyes, or clay-colored stools.
- A swollen face, lips, tongue or throat, difficulty breathing or a severe rash.
- A neck lump, a hoarse voice or difficulty swallowing (see the boxed warning).
- Sudden vision loss.
- A racing heartbeat at rest that lasts several minutes.
Wegovy pill side effects
Similar to the injection. In the tablet’s trial, the types and rates of common side effects were close to the 2.4 mg pen’s, and 6.9% of people stopped over side effects (5.9% on placebo).2
Side effects at 7.2 mg
Altered skin sensation is the main difference: 22% at 7.2 mg, 6% at 2.4 mg, none on placebo. Nausea was 39% against 35%, and hair loss 6% against 3%.2
How many people stop Wegovy?
In adult trials, 6.8% of people on the 2.4 mg pen stopped treatment over side effects. On placebo, 3.2% did.2
What changed on the label in 2026
The suicidal thoughts warning was removed after an FDA review found no increased risk.14 In November 2026 the FDA ordered a new warning for all GLP-1 medicines about a possible link to NAION, a rare cause of sudden vision loss.15 See GLP-1 side effects.
Wegovy dosing schedule: 0.25 mg to 2.4 mg in 17 weeks
Wegovy injections start at 0.25 mg once a week and rise every four weeks, reaching the 2.4 mg maintenance dose in week 17. The slow start limits stomach side effects.2
| Weeks | Weekly dose | What it is for |
|---|---|---|
| 1 to 4 | 0.25 mg | Starting dose |
| 5 to 8 | 0.5 mg | Step up |
| 9 to 12 | 1 mg | Step up |
| 13 to 16 | 1.7 mg | Step up. Also a maintenance option |
| 17 onward | 2.4 mg | Recommended maintenance dose |
| Later, if needed | 7.2 mg | Adult maximum, after 4 weeks or more on 2.4 mg |
- 0.25 mgWeeks 1 to 4
- 0.5 mgWeeks 5 to 8
- 1 mgWeeks 9 to 12
- 1.7 mgWeeks 13 to 16
- 2.4 mgWeek 17 on
- 7.2 mgAdult maximum
Schedule from the Wegovy label.2 If a step is hard to tolerate, your provider can delay the next increase by four weeks. Tablet schedule: Wegovy pill dosing.
How to inject Wegovy
Pick one day of the week and keep to it. Any time of day works, with or without food. Inject into the abdomen, thigh or upper arm, and rotate the site. Store pens in the refrigerator.2
Missed a dose?
If the next dose is over 2 days (48 hours) off, take the missed one now. Otherwise skip it. After two or more missed doses, ask your provider before restarting.2
How much does Wegovy cost? Coupon, insurance and cash prices
A month of Wegovy can cost as little as $25 with commercial insurance that covers it, $149 to $399 at Novo Nordisk’s self-pay prices, or $1,349.02 at list price.8,16
| Your situation | What you may pay | Details |
|---|---|---|
| Covered by a commercial plan | As little as $25 a month | Novo Nordisk’s savings offer removes up to $100 per one-month fill.8 |
| Cash, Wegovy pen | $349 a month. $399 for 7.2 mg | New patients: $199 for the first two fills of 0.25 mg or 0.5 mg. Ends December 31, 2026.17 |
| Cash, Wegovy pill | $149 to $299 a month | 1.5 mg: $149. 4 mg: $199. 9 mg and 25 mg: $299.8 |
| Medicare Part D | $50 a month if eligible | Medicare GLP-1 Bridge, which started July 1, 2026 and ends December 31, 2027.18 |
| Medicaid, TRICARE, VA | Varies by program | Cannot use the savings offer.8 |
| Not covered, through Zealthy | $199 a month, or from $106 | Compounded semaglutide. Not FDA-approved. |
Novo Nordisk can change or end these offers without notice. Zealthy membership is separate.
Wegovy cost with insurance
You pay your plan’s copay, and the savings offer can cut it to as little as $25. The offer is capped at $100 a month, so a $200 copay becomes $100.8 Zealthy’s insurance team submits the prior authorization, and your plan decides. Check first with our GLP-1 insurance checker.
People with Medicare cannot use the offer, but the Medicare GLP-1 Bridge sets a $50 copay for those who qualify.18
Wegovy cost without insurance
The pen is $349 a month at every strength up to 2.4 mg and $399 for 7.2 mg. The pill is $149, $199 or $299 by strength.8 The $199 intro price is for new patients’ first two fills of 0.25 mg or 0.5 mg, and it ends with fills on December 31, 2026.17 Cash fills run outside insurance.
Wegovy coupon: how the savings offer works
The “Wegovy coupon” is Novo Nordisk’s Wegovy savings offer.8
- It needs a prescription for an FDA-approved use and commercial insurance that covers Wegovy.
- It saves up to $100 on a one-month fill, $200 on two months, $300 on three.
- It covers every pen and tablet strength.
- People enrolled in Medicare, Medicaid, VA or TRICARE cannot use it.
- It cannot be combined with another coupon or a cash discount card.
A GoodRx Wegovy coupon is the same Novo Nordisk self-pay pricing, administered by GoodRx.19 See our GoodRx Wegovy guide.
What you pay through Zealthy
- Membership: $39 in the first month, $135 in each month that follows. Medication is extra.
- Brand Wegovy: your plan’s copay, as low as $25 a month when covered, filled at your own pharmacy.
- Compounded semaglutide: $199 a month, or from $106 a month with a 3-month supply, shipping included. Bundled with membership: $217 the first month, $297 a month after.
Compounded semaglutide is not FDA-approved. The FDA does not review compounded drugs for safety, effectiveness or quality.4
Can you get Wegovy from NovoCare without a prescription?
No. NovoCare, run by Novo Nordisk, is a pharmacy service that delivers to your home. It ships Wegovy free at the self-pay price or through insurance, but the prescription must first come from a licensed clinician.20
| Feature | Zealthy | NovoCare |
|---|---|---|
| Who prescribes | A Zealthy provider, when appropriate | Your own clinician, or a telehealth prescriber it refers you to |
| Insurance | We submit the prior authorization | Self-pay or insurance |
| If Wegovy is not covered | Compounded semaglutide from $106/mo. Not FDA-approved | Brand Wegovy at self-pay prices |
| Ongoing support | Messaging, optional visits and a coach | From your prescriber |
Zealthy has no affiliation with NovoCare or Novo Nordisk. The federal site TrumpRx.gov also shows the Wegovy pen from $199 a month, which mirrors the self-pay intro price.21
Wegovy vs. Zepbound, Ozempic, Mounjaro and compounded semaglutide
Of the four brands Zealthy providers prescribe, Wegovy and Zepbound are approved for weight loss. Ozempic® and Mounjaro® are approved for type 2 diabetes, so using either for weight is off-label.
Swipe sideways to see all five columns.
| Feature | Wegovy | Zepbound | Ozempic | Mounjaro | Compounded semaglutide |
|---|---|---|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide | Semaglutide | Tirzepatide | Semaglutide |
| FDA-approved for | Weight loss, heart risk reduction, MASH2 | Weight loss, obstructive sleep apnea with obesity22 | Type 2 diabetes23 | Type 2 diabetes24 | Not FDA-approved |
| How it is taken | Weekly injection or daily pill | Weekly injection | Weekly injection or daily pill | Weekly injection | Weekly injection |
| Top weekly dose | 7.2 mg | 15 mg | 2 mg | 15 mg | Set by prescriber |
| Weight change in a key trial | 14.9% at 68 weeks (STEP 1)1 | 15.0% to 20.9% at 72 weeks (SURMOUNT-1)25 | 12.6 lb at 40 weeks (SURPASS-2)24 | 16.8 to 24.7 lb at 40 weeks (SURPASS-2)24 | No trials of its own |
| Through Zealthy | Copay as low as $25/mo when your plan covers it | From $106/mo | |||
Averages from separate trials. SURPASS-2 enrolled adults with type 2 diabetes and used Ozempic 1 mg.
Wegovy vs. Zepbound, head to head
SURMOUNT-5 compared the two weight loss drugs directly. Over 72 weeks, 751 adults with obesity lost 20.2% on tirzepatide and 13.7% on semaglutide on average. It was open-label and funded by Eli Lilly.11 Wegovy has a heart indication and a pill form. Zepbound has a sleep apnea indication.2,22
What Zealthy weight loss members say
One of the things I appreciate most about semaglutide is its convenience. The once-weekly dosing schedule has made it incredibly easy to integrate into my routine. It's a relief to know that I don't have to worry about multiple daily injections or complicated medication schedules.
I started semaglutide at the recommendation of my Zealthy provider and I'm so happy with that decision. I signed up for their weight loss program and they've been giving me everything I need to make better lifestyle choices to get results that last. And the program's super affordable. 10/10 I can't recommend this enough.
Getting support a weight loss program has always been hard for me. I had been wanting to start one with a medication component for a while and Zealthy was the first one that made it easy for me with weight loss shots sent to me. They made it SO affordable and the medical team is great.
Since I started, I have already lost 35 pounds and feel so much better. My doctor also helped me get a prescription for ozempic and he is always available to answer my questions in the message portal. This made me feel a lot more comfortable and excited to lose weight.
The weight loss program is fantastic. Everyone has been so helpful and has helped me feel much more excited about the process. I was nervous to see my weight loss treatment plan, since I have done programs in the past, but they always wanted me to make drastic changes. I mentioned all of this to my weight loss coach and she was very understanding and made a customized plan for me.
I've been a member for 6 months now and have received all my medication every 3 months. Everyone has been so helpful and my care team is always available to help me!
Individual results may vary. These are the experiences of Zealthy members and are not a guarantee of any outcome. Medication is prescribed only when a licensed provider finds it appropriate.

Licensed providers decide whether Wegovy fits you
A U.S.-licensed physician or nurse practitioner reads your health history before any Wegovy prescription is written. If the pen, the pill or semaglutide itself is the wrong choice, they will tell you and explain what they would consider instead.
The medical information on this page is reviewed by the Zealthy care team against FDA prescribing information and published clinical trials. It is general education, not personal medical advice.
Wegovy FAQs
How do I get a Wegovy prescription online?
Complete Zealthy’s online intake and a licensed provider decides whether Wegovy is appropriate. No live appointment is needed to start. If Wegovy is prescribed, it goes to your own pharmacy and our insurance team files the prior authorization. Membership is $39 for month one, then $135 monthly.
How much is Wegovy a month without insurance?
As of November 2026, the self-pay price from Novo Nordisk is $349 a month for the Wegovy pen, $399 for the 7.2 mg pen and $149 to $299 for the pill. New patients pay $199 for their first two fills of 0.25 mg or 0.5 mg through December 31, 2026.
Who can use the Wegovy savings card?
People with commercial insurance that covers Wegovy and a prescription for an approved use. The offer lowers a one-month fill to as little as $25 and takes off no more than $100. Anyone enrolled in Medicare, Medicaid, TRICARE or VA drug coverage is excluded. See how it works.
Will my insurance pay for Wegovy?
It depends on your plan. Zealthy’s insurance coordination team submits the prior authorization for brand Wegovy, and when the plan approves, your copay can be as low as $25 a month. If it does not, ask your provider about other options. Our GLP-1 insurance checker is a quick first look.
Does Medicare cover Wegovy in 2026?
It can. The Medicare GLP-1 Bridge gives eligible Part D enrollees the Wegovy pen or pill for a $50 monthly copay. It began on July 1, 2026 and runs to December 31, 2027. Eligibility depends on BMI and related conditions.18 People with Medicare cannot use the $25 savings offer.
Does the Wegovy pill work as well as the shot?
No trial has compared them directly. In separate studies, adults lost 13.6% of their weight on the 25 mg tablet at 64 weeks and 14.9% on the 2.4 mg injection at 68 weeks, on average. Individual results vary. See Wegovy pill vs. pen.
What is the most common side effect of Wegovy?
Nausea. In adult trials, 44% of people on Wegovy 2.4 mg had it, and so did 16% of the placebo group. Diarrhea (30%), vomiting (24%), constipation (24%) and stomach pain (20%) followed. They were most frequent while the dose was increasing. See the side effect table.
Do Wegovy side effects go away?
Often, yes. Novo Nordisk describes nausea on Wegovy as generally temporary, and stomach side effects were most frequent during the dose increases of the first 16 weeks. If a dose is hard to tolerate, your provider can delay the next step by four weeks.2,13
Does Wegovy cause hair loss?
It can, but it is uncommon. Hair loss was reported by 3.3% of adults on Wegovy 2.4 mg and 1% on placebo, and by 5.8% at the 7.2 mg dose. It was more frequent in women. The label associates it with weight reduction.2
Does Wegovy still carry a warning about suicidal thoughts?
No. In January 2026 the FDA said its review of 91 trials covering 107,910 patients found no increased risk of suicidal thoughts or behavior with GLP-1 medicines, and the warning was removed from the Wegovy label.14 Still tell your provider about any change in mood.
What is Wegovy HD 7.2 mg?
Wegovy HD is the 7.2 mg weekly pen, approved by the FDA on March 19, 2026 for adults who need more weight reduction after at least four weeks on 2.4 mg. In the STEP UP trial, average weight loss was 18.7% on 7.2 mg and 15.6% on 2.4 mg.
What is the difference between Wegovy and Ozempic?
Both are semaglutide from Novo Nordisk, but they are separate products. Wegovy is approved for weight reduction at up to 7.2 mg a week. The approval for Ozempic covers type 2 diabetes, at up to 2 mg a week, so using it for weight loss is off-label.
Is Zepbound or Wegovy better for weight loss?
In a head-to-head trial, SURMOUNT-5, adults lost 20.2% of their weight on tirzepatide (Zepbound) and 13.7% on semaglutide (Wegovy) over 72 weeks, on average. The trial was funded by Zepbound’s maker. Coverage, side effects and your health history also matter.
Will I regain weight if I stop Wegovy?
Most people regain some. In the STEP 4 trial, adults switched to placebo after 20 weeks regained 6.9% of their weight over the next 48 weeks, while those who stayed on Wegovy lost a further 7.9%. Talk to your provider before stopping.
Is compounded semaglutide the same as Wegovy?
No. Compounded semaglutide is made by a pharmacy for an individual prescription. It is not FDA-approved or a generic, and the FDA does not review it for safety, effectiveness or quality. Wegovy’s trial results do not apply to it. Through Zealthy it starts at $106 a month with a 3-month supply.
More on Wegovy and GLP-1 medication
Important safety information
Boxed warning: thyroid C-cell tumor risk
In rodent studies, semaglutide caused thyroid C-cell tumors. Nobody knows whether Wegovy does the same in people, including a cancer called medullary thyroid carcinoma (MTC). Wegovy is not for anyone who has had MTC, anyone with a close relative who has, or anyone with MEN 2 (Multiple Endocrine Neoplasia syndrome type 2). Report a neck lump, difficulty swallowing, shortness of breath or lasting hoarseness to your provider.2
Do not take Wegovy if
- You or a close relative has ever had MTC, or you have MEN 2.
- Semaglutide, or another ingredient in Wegovy, has ever given you a serious allergic reaction.
Tell your provider before you start if you
- Have had pancreas or kidney problems.
- Have type 2 diabetes with diabetic retinopathy, or take insulin or a sulfonylurea.
- Have surgery or a procedure with anesthesia planned.
- Are pregnant or planning to be. Stop Wegovy at least 2 months before a planned pregnancy.
- Are breastfeeding. It is not recommended with Wegovy tablets.
- Take another GLP-1 medicine.
Possible serious side effects
Pancreatitis, gallbladder problems including gallstones, low blood sugar, kidney injury from dehydration, severe stomach problems, serious allergic reactions, changes in eyesight for people who have type 2 diabetes, a faster heart rate, and food or liquid entering the lungs during anesthesia.2 The FDA is also adding a warning about NAION, a rare cause of sudden vision loss.15
Common side effects
The ones reported most are nausea, diarrhea, vomiting, constipation, stomach pain, changes in skin sensation, headache, tiredness, dizziness, upset stomach, bloating, belching, gas, stomach flu, heartburn, hair loss and, in type 2 diabetes, low blood sugar.13
This is a summary, not the full label. Read the Prescribing Information and Medication Guide. Side effects can be reported to the FDA: call 1-800-FDA-1088 or visit fda.gov/medwatch.
Sources
- Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/
- Wegovy (semaglutide) injection and tablets prescribing information. Novo Nordisk. Revised June 2026. https://www.novo-pi.com/wegovy.pdf
- Novo Nordisk. FDA approves oral Wegovy pill. December 22, 2025. https://www.novonordisk-us.com/media/press-releases/wegovy-pill-fda-approval-obesity.html
- U.S. Food and Drug Administration. FDA’s concerns with unapproved GLP-1 drugs used for weight loss. https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss
- U.S. Food and Drug Administration. FDA approves fourth product under National Priority Voucher program, higher dose semaglutide. March 19, 2026. https://www.fda.gov/news-events/press-announcements/fda-approves-fourth-product-under-national-priority-voucher-program-higher-dose-semaglutide
- Wharton S, Freitas P, Hjelmesæth J, et al. Once-weekly semaglutide 7.2 mg in adults with obesity (STEP UP). Lancet Diabetes Endocrinol. 2025;13(11):949-963. https://pubmed.ncbi.nlm.nih.gov/40961952/
- Wharton S, Lingvay I, Bogdanski P, et al. Oral semaglutide at a dose of 25 mg in adults with overweight or obesity (OASIS 4). N Engl J Med. 2025;393(11):1077-1087. https://pubmed.ncbi.nlm.nih.gov/40934115/
- Novo Nordisk. Wegovy Savings Offer terms and conditions. https://www.wegovyterms.com
- Garvey WT, Batterham RL, Bhatta M, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nat Med. 2022;28(10):2083-2091. https://pubmed.ncbi.nlm.nih.gov/36216945/
- Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and cardiovascular outcomes in obesity without diabetes (SELECT). N Engl J Med. 2023;389(24):2221-2232. https://pubmed.ncbi.nlm.nih.gov/37952131/
- Aronne LJ, Horn DB, le Roux CW, et al. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). N Engl J Med. 2025;393(1):26-36. https://pubmed.ncbi.nlm.nih.gov/40353578/
- Rubino D, Abrahamsson N, Davies M, et al. Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity (STEP 4). JAMA. 2021;325(14):1414-1425. https://pubmed.ncbi.nlm.nih.gov/33755728/
- Novo Nordisk. Wegovy side effects and tips for managing nausea. https://www.wegovy.com/taking-wegovy/side-effects.html
- U.S. Food and Drug Administration. FDA requests removal of suicidal behavior and ideation warning from glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications. January 13, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requests-removal-suicidal-behavior-and-ideation-warning-glucagon-peptide-1-receptor-agonist-glp
- U.S. Food and Drug Administration. FDA requires safety labeling changes for glucagon-like peptide-1 receptor agonists (GLP-1 RAs) due to potential increased risk of rare but serious eye condition. Drug Safety Communication, November 9, 2026. https://www.fda.gov/drugs/drug-safety-communications/fda-requires-safety-labeling-changes-glucagon-peptide-1-receptor-agonists-glp-1-ras-due-potential
- Novo Nordisk. Wegovy list price (NovoPricing). https://www.novopricing.com/wegovy.html
- Novo Nordisk. Wegovy cost and coverage information. https://www.wegovy.com/coverage-and-savings/save-on-wegovy.html
- Medicare.gov. Weight loss drugs (Medicare GLP-1 Bridge). https://www.medicare.gov/glp1bridge
- GoodRx. Wegovy coupon terms and conditions, administered by GoodRx on behalf of Novo Nordisk. September 2026. https://www.grxstatic.com/bds/wegovy-offer-terms-and-conditions.pdf
- Novo Nordisk. NovoCare home delivery for GLP-1 medicines. https://www.novocare.com/pharmacy.html
- TrumpRx. https://trumprx.gov/
- Zepbound (tirzepatide) prescribing information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/zepbound-uspi.pdf
- Ozempic (semaglutide) injection prescribing information. Novo Nordisk. Revised May 2026. https://www.novo-pi.com/ozempic.pdf
- Mounjaro (tirzepatide) prescribing information. Eli Lilly and Company. Revised August 2026. https://pi.lilly.com/us/mounjaro-uspi.pdf
- Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/
Reviewed by the Zealthy care team. Web sources accessed November 18, 2026.
See whether Wegovy fits your health history
Answer the intake questions online and a licensed provider reviews them. Your first month of membership costs $39.
Get Started